Literature DB >> 19723756

A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome.

Katherine U Gaynor1, Irina V Grigorieva, M Andrew Nesbit, Treena Cranston, Thushari Gomes, Ludwig Gortner, Rajesh V Thakker.   

Abstract

CONTEXT: The hypoparathyroidism, deafness, renal dysplasia (HDR) syndrome is caused by mutations in the gene encoding GATA3, which belongs to a family of dual zinc-finger transcription factors that have a role in vertebrate embryonic development.
OBJECTIVE: The aim of the study was to identify the GATA3 mutation in a HDR patient and determine its functional consequences. PATIENT AND
DESIGN: A patient with HDR was studied after approval from the local ethical committee. Leukocyte DNA was used with GATA3-specific primers for PCR amplification, and the DNA sequences of the PCR products were determined. Wild-type and mutant GATA3 constructs were transfected into COS-7 cell, and their functions were assessed by Western blot analysis, immunocytochemistry, EMSAs, luciferase reporter assays, and three-dimensional modeling.
RESULTS: A novel missense mutation, Thr272Ile, in zinc finger 1 (ZnF1) of GATA3 was identified. Western blot analysis and immunofluorescence revealed that the mutation did not affect nuclear localization of GATA3. However, EMSAs showed it to reduce DNA binding affinity, but not stability, and yeast two-hybrid assays demonstrated that the mutant GATA3 resulted in a loss of interaction with ZnF1 and ZnF6 of the cofactor FOG2. The mutant GATA3 significantly reduced luciferase reporter activity by more than 65% (P < 0.001), and three-dimensional modeling indicated that the functional abnormalities may be due to a loss of Thr272 polar side chain interaction with Leu268.
CONCLUSIONS: A novel missense HDR-associated GATA3 mutation, Thr272Ile, has been identified and shown to result in reduced DNA binding, a partial loss of FOG2 interaction, and a decrease in gene transcription.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723756     DOI: 10.1210/jc.2009-0717

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2.

Authors:  Irina V Grigorieva; Samantha Mirczuk; Katherine U Gaynor; M Andrew Nesbit; Elena F Grigorieva; Qiaozhi Wei; Asif Ali; Rebecca J Fairclough; Joanna M Stacey; Michael J Stechman; Radu Mihai; Dorota Kurek; William D Fraser; Tertius Hough; Brian G Condie; Nancy Manley; Frank Grosveld; Rajesh V Thakker
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

2.  Renal phenotypic variability in HDR syndrome: glomerular nephropathy as a novel finding.

Authors:  Alexis Chenouard; Bertrand Isidor; Emma Allain-Launay; Anne Moreau; Marc Le Bideau; Gwenaelle Roussey
Journal:  Eur J Pediatr       Date:  2012-10-05       Impact factor: 3.183

3.  Novel dominant-negative mutant of GATA3 in HDR syndrome.

Authors:  Masaaki Ohta; Minenori Eguchi-Ishimae; Mayumi Ohshima; Hidehiko Iwabuki; Koji Takemoto; Kikuko Murao; Toshiyuki Chisaka; Eiichi Yamamoto; Takashi Higaki; Keiichi Isoyama; Mariko Eguchi; Eiichi Ishii
Journal:  J Mol Med (Berl)       Date:  2010-12-01       Impact factor: 4.599

4.  A Novel Role for GATA3 in Mesangial Cells in Glomerular Development and Injury.

Authors:  Irina V Grigorieva; Andre Oszwald; Elena F Grigorieva; Helga Schachner; Barbara Neudert; Tammo Ostendorf; Jürgen Floege; Maja T Lindenmeyer; Clemens D Cohen; Ulf Panzer; Christof Aigner; Alice Schmidt; Frank Grosveld; Rajesh V Thakker; Andrew Jackson Rees; Renate Kain
Journal:  J Am Soc Nephrol       Date:  2019-08-12       Impact factor: 10.121

5.  GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness.

Authors:  Katherine U Gaynor; Irina V Grigorieva; Michael D Allen; Christopher T Esapa; Rosemary A Head; Preethi Gopinath; Paul T Christie; M Andrew Nesbit; J Louise Jones; Rajesh V Thakker
Journal:  Horm Cancer       Date:  2013-02-22       Impact factor: 3.869

6.  The first Korean case of HDR syndrome confirmed by clinical and molecular investigation.

Authors:  Chong Kun Cheon; Gu Hwan Kim; Han Wook Yoo
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

7.  A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome.

Authors:  Tetsuji Okawa; Masanori Yoshida; Takeshi Usui; Takahiro Kudou; Yasumasa Iwasaki; Kazuki Fukuoka; Norio Takahashi; Yuka Uehara; Yutaka Oiso
Journal:  BMC Endocr Disord       Date:  2015-10-30       Impact factor: 2.763

8.  Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3.

Authors:  M Andrew Nesbit; Fadil M Hannan; Sarah A Howles; Anita A C Reed; Treena Cranston; Clare E Thakker; Lorna Gregory; Andrew J Rimmer; Nigel Rust; Una Graham; Patrick J Morrison; Steven J Hunter; Michael P Whyte; Gil McVean; David Buck; Rajesh V Thakker
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

9.  A Novel De Novo GATA Binding Protein 3 Mutation in a Turkish Boy with Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome.

Authors:  Gül Yeşiltepe Mutlu; Heves Kırmızıbekmez; Akie Nakamura; Maki Fukami; Şükrü Hatun
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12

10.  HDR syndrome with a novel mutation in GATA3 mimicking a congenital X-linked stapes gusher: a case report.

Authors:  Aram Yang; Jinsup Kim; Chang-Seok Ki; Sung Hwa Hong; Sung Yoon Cho; Dong-Kyu Jin
Journal:  BMC Med Genet       Date:  2017-10-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.